Acadia Pharmaceuticals (ACAD) is down -11.2%, or -$2.63 to $20.96.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACAD:
- Positive Outlook for ACADIA Pharmaceuticals Despite Setbacks: Buy Rating Justified
- Video: Lithium Americas jumps amid talks with DOE, General Motors on loan
- Morning Movers: uniQure skyrockets after AMT-130 trial meets primary endpoint
- Balanced Hold Rating for ACADIA Pharmaceuticals Amid Trial Setback and Growth Potential
- Morgan Stanley sees ‘small impact’ on Acadia valuation from ACP-101 failure